Update on pancreatic transplantation on the management of diabetes
- PMID: 28466634
- DOI: 10.23736/S0026-4806.17.05224-7
Update on pancreatic transplantation on the management of diabetes
Abstract
Pancreas transplantation is the only therapy that can restore insulin independence in beta-cell penic diabetic recipients. Because of the need for life-long immunosuppression and the intial surgical risk associated with the transplant procedure, Pancreas transplantation is a therapeutic option only in selected diabetic patients. Based on renal function, three main populations of diabetic recipients of a pancreas transplant can be identified: uremic patients, posturemic patients (following successful kidney transplantation), and non-uremic patients. Uremic patients are best treated by simultaneous kidney-pancreas transplantation with grafts obtained from the same deceased donor. Posturemic patients can receive a pancreas after kidney transplantation, if the previous renal graft has a good functional reserve. Non-uremic patients can receive a pancreas alone transplant if their diabetes is poorly controlled, despite optimal insulin therapy, suffer from unawareness hypoglycemia events and/or develop progressive chronic complications of diabetes. The results of pancreas transplantation have improved over the years and are currently not inferior to those of renal transplantation in non-diabetic recipients. A functioning pancreatic graft can prolong the life of diabetic recipients, improves their quality of life, and can halt, or reverse, the progression of chronic complications of diabetes. Unfortunately, because of ageing of donor population and lack of timely referral of potential recipients, the annual volume of pancreas transplants is declining. Considering that the results of pancreas transplantation depend on center volume, and that adequate center volume is required also for training of newer generations of transplant physcians and surgeons, centralization of pancreas transplantation activity should be considered.
Similar articles
-
Update on Pancreatic Transplantation in the Management of Diabetes.2021 Aug 17. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2021 Aug 17. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905213 Free Books & Documents. Review.
-
Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.Am J Kidney Dis. 2003 Feb;41(2):464-70. doi: 10.1053/ajkd.2003.50057. Am J Kidney Dis. 2003. PMID: 12552511
-
The case for pancreas transplantation.Diabetes Metab. 1996 Apr;22(2):132-8. Diabetes Metab. 1996. PMID: 8792093 Review.
-
[Pancreas transplantation: a survey on indications, surgical techniques, immunosuppression, complications and outcome].Zentralbl Chir. 2003 Oct;128(10):821-30. doi: 10.1055/s-2003-44336. Zentralbl Chir. 2003. PMID: 14628231 German.
-
Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease.Arch Surg. 1997 Apr;132(4):358-61; discussion 361-2. doi: 10.1001/archsurg.1997.01430280032004. Arch Surg. 1997. PMID: 9108755
Cited by
-
Generation of a Transgenic Zebrafish Model for Pancreatic Beta Cell Regeneration.Galen Med J. 2019 Nov 6;8:e1056. doi: 10.31661/gmj.v8i0.1056. eCollection 2019. Galen Med J. 2019. PMID: 34466457 Free PMC article.
-
Reseeding endothelial cells with fibroblasts to improve the re-endothelialization of pancreatic acellular scaffolds.J Mater Sci Mater Med. 2019 Jul 10;30(7):85. doi: 10.1007/s10856-019-6287-x. J Mater Sci Mater Med. 2019. PMID: 31292746
-
Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology.Front Endocrinol (Lausanne). 2018 Aug 31;9:445. doi: 10.3389/fendo.2018.00445. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30233489 Free PMC article. Review.
-
Novel technique for arterial reconstruction in simultaneous pancreas-kidney transplantation, a randomized clinical trial.BMC Res Notes. 2023 Oct 26;16(1):295. doi: 10.1186/s13104-023-06568-9. BMC Res Notes. 2023. PMID: 37885028 Free PMC article. Clinical Trial.
-
Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery.ACS Nano. 2022 Nov 22;16(11):18223-18231. doi: 10.1021/acsnano.2c05687. Epub 2022 Nov 2. ACS Nano. 2022. PMID: 36322923 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical